Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Denton

Showing results (121-130 of 607) with videos related to

Pageof 61
Sort By:
Experimental Physiology|September 10, 2025
Suppression of premature ventricular complexes with the PDE5 inhibitor sildenafil: First clinical experienceDavid C Hutchings, Christopher P Denton, Luigi Venetucci, et al.
Clinical and Experimental Rheumatology|February 28, 2020
Developing a quantitative tool to evaluate dermal fibrosis in systemic sclerosis patients: a case-control studyIraklis Giannakopoulos, Michelle Griffin, Christopher P Denton, et al.
Clinical and Experimental Rheumatology|February 22, 2018
Development of systemic sclerosis in transgender females: a case series and review of the literatureCorrado Campochiaro, Lauren V Host, Voon H Ong, et al.
The Journal of Investigative Dermatology|March 1, 1997
Scleroderma fibroblasts show increased responsiveness to endothelial cell-derived IL-1 and bFGFC P Denton, S Xu, C M Black, et al.
Clinical Rheumatology|April 15, 2020
Challenges in physician-patient communication for optimal management of systemic sclerosis-associated interstitial lung disease: a discourse analysisChristopher P Denton, Bee Laird, Lizette Moros, et al.
Nature Reviews. Rheumatology|September 8, 2025
Emerging therapies for the treatment of systemic sclerosisJörg H W Distler, Masataka Kuwana, Shervin Assassi, et al.
Clinical Rheumatology|September 11, 2020
Things left unsaid: important topics that are not discussed between patients with systemic sclerosis, their carers and their healthcare professionals-a discourse analysisChristopher P Denton, Bee Laird, Lizette Moros, et al.
Clinical and Experimental Rheumatology|August 19, 2000
Long-term low molecular weight heparin therapy for severe Raynaud's phenomenon: a pilot studyC P Denton, K Howell, R J Stratton, et al.
Rheumatology (Oxford, England)|June 3, 2009
Digital ulcers: overt vascular disease in systemic sclerosisV Steen, C P Denton, J E Pope, et al.
The British Journal of Ophthalmology|July 19, 2005
Bilateral ischaemic retinal vasculopathy in sclerodermaM Minasian, M Stanford, E Graham, et al.
Pageof 61

Showing results (121-130 of 607) with videos related to

Sort By:
Pageof 61
Experimental Physiology|September 10, 2025
Suppression of premature ventricular complexes with the PDE5 inhibitor sildenafil: First clinical experienceDavid C Hutchings, Christopher P Denton, Luigi Venetucci, et al.
Clinical and Experimental Rheumatology|February 28, 2020
Developing a quantitative tool to evaluate dermal fibrosis in systemic sclerosis patients: a case-control studyIraklis Giannakopoulos, Michelle Griffin, Christopher P Denton, et al.
Clinical and Experimental Rheumatology|February 22, 2018
Development of systemic sclerosis in transgender females: a case series and review of the literatureCorrado Campochiaro, Lauren V Host, Voon H Ong, et al.
The Journal of Investigative Dermatology|March 1, 1997
Scleroderma fibroblasts show increased responsiveness to endothelial cell-derived IL-1 and bFGFC P Denton, S Xu, C M Black, et al.
Clinical Rheumatology|April 15, 2020
Challenges in physician-patient communication for optimal management of systemic sclerosis-associated interstitial lung disease: a discourse analysisChristopher P Denton, Bee Laird, Lizette Moros, et al.
Nature Reviews. Rheumatology|September 8, 2025
Emerging therapies for the treatment of systemic sclerosisJörg H W Distler, Masataka Kuwana, Shervin Assassi, et al.
Clinical Rheumatology|September 11, 2020
Things left unsaid: important topics that are not discussed between patients with systemic sclerosis, their carers and their healthcare professionals-a discourse analysisChristopher P Denton, Bee Laird, Lizette Moros, et al.
Clinical and Experimental Rheumatology|August 19, 2000
Long-term low molecular weight heparin therapy for severe Raynaud's phenomenon: a pilot studyC P Denton, K Howell, R J Stratton, et al.
Rheumatology (Oxford, England)|June 3, 2009
Digital ulcers: overt vascular disease in systemic sclerosisV Steen, C P Denton, J E Pope, et al.
The British Journal of Ophthalmology|July 19, 2005
Bilateral ischaemic retinal vasculopathy in sclerodermaM Minasian, M Stanford, E Graham, et al.
Pageof 61